Mergers and Acquisitions

J&J Accepts $2.1-Billion Offer for Diabetes Solutions Business

June 19, 2018

Johnson & Johnson has accepted an offer from Platinum Equity to acquire diabetes solutions business LifeScan for $2.1 billion.

Bayer Completes Monsanto Acquisition for $63 Billion

June 13, 2018

Bayer completed its acquisition of Monsanto, the largest in Bayer’s history.

Agilent Acquires Genohm to Improve Lab Informatics

June 01, 2018

Pharmaceutical Technology's In the Lab eNewsletter

Agilent Technologies expects the acquisition to improve its current software portfolio.

Bayer Gets US Approval for $66-Billion Acquisition of Monsanto

May 30, 2018

Bayer received conditional approval from the Antitrust Division of the United States Department of Justice to acquire Monsanto in a deal worth $66 billion.

Vectalys, FlashCell Merge to Form Gene Therapy Company

May 23, 2018

The new company will develop proprietary RNA-based therapeutics and will provide broad lentiviral development and manufacturing expertise and support.

Lilly to Acquire AurKa Pharma in Deal Worth Up to $575 million

May 21, 2018

The acquisition of AurKa Pharma will help strength Eli Lilly’s oncology pipeline.

Novartis Acquires AveXis for $8.7 Billion

May 16, 2018

The acquisition is expected to strengthen Novartis’ gene therapy pipeline.

Lilly to Acquire ARMO BioSciences for $1.6 Billion

May 15, 2018

Eli Lilly will acquire ARMO BioSciences to strengthen Lilly's immuno-oncology program.

J&J’s Janssen to Acquire BeneVir for $1 Billion

May 09, 2018

Johnson & Johnson’s Janssen Biotech will acquire biotechnology company BeneVir Biopharm to strengthen Janssen’s immunotherapy platform.

Fresenius Terminates $4.3-Billion Merger with Akron

May 01, 2018

Fresenius Kabi claims that Akorn failed to fulfill several closing conditions.